Linyi, Saint Helena

Zhenyu Li

This inventor holds 1 USPTO granted patent. Top assignee: Shandong New Time Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhenyu Li. Retrieved from https://idiyas.com/inventor/zhenyu-li-bc6qdvcf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhenyu Li: Innovator in Bispecific Antibody Treatment

Introduction

Zhenyu Li is a prominent inventor based in Linyi, Shandong, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments using bispecific antibodies.

Latest Patents

Zhenyu Li holds a patent for a groundbreaking invention titled "Method of Treatment Using a Bispecific Antibody Binding BCMA and CD3." This patent represents a significant advancement in therapeutic approaches for various diseases.

Career Highlights

Zhenyu Li is currently employed at Shandong New Time Pharmaceutical Co., Ltd. His work at this company focuses on the research and development of novel pharmaceutical solutions. His expertise in antibody technology has positioned him as a key figure in the industry.

Collaborations

Zhenyu Li collaborates with talented colleagues, including Qiang Li and Yuan Yan. Together, they work on innovative projects that aim to enhance treatment options in the pharmaceutical sector.

Conclusion

Zhenyu Li's contributions to the field of biotechnology and his innovative patent demonstrate his commitment to advancing medical treatments. His work continues to inspire future developments in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…